Getting the Answers

Last month, you may have seen a post on my Facebook page about an interview I had done with Medscape. A few weeks later, the interview was made available to the general public on WebMD. The main focus of the interview was to allow me to explain how and why gluten and carbohydrates represent such a powerful threat to the human brain. Now that the article has had a chance to disseminate across the internet, I’ve seen a flood of comments from medical practitioners, industry experts, and interested individuals, asking questions, providing anecdotal evidence, offering support, and much, much more. So, I wanted to take an opportunity to acknowledge some of these comments, offer thanks, and provide some answers. (All comments sourced from the posting on Medscape From Craig Petersen: …I would be interested to see how the author works out the math, regarding the suggested daily carbohydrate intake of 60 grams, while conceiving an actual healthy diet that provides an adequate intake of calories…Just to translate 60 grams of carbohydrate in real terms, that number would be achieved with 1/2 cup of legumes, a slice of white bread, and a serving of fruit. This would leave no room for any other sources of carbohydrate like vegetables, potatoes, rice, cereal, corn, any refined sugars at all, milk, yogurt, cheese, or even nuts which contain relatively modest amounts of carbohydrate. Assuming a relatively high protein intake of 100 grams, which will need to come primarily ...
Source: Renegade Neurologist - A Blog by David Perlmutter, MD, FACN - Category: Neurologists Authors: Tags: Grain Brain Nutrition Science athletes calories carbs cereal Diet exercise fat fruit Grains medscape Paleo protein sugar webmd white bread Source Type: blogs

Related Links:

In this study, fluorescence emission spectroscopy and mass spectrometry (MALDI-TOF) were employed to define the putative interaction sites and their accessibility for the biologically important metals of Irving William Series.Key findingsSeveral hotspot residues in the ZAG scaffold involved in these interactions were mapped and their binding affinity score for each metal has been determined. Their binding abilities of these sites and aggregation propensities of ZAG were monitored by fluorescence emission spectroscopy.SignificanceThe prediction of such binding affinity with metals on the active sites and its impact on the c...
Source: Life Sciences - Category: Biology Source Type: research
Authors: Gluszewska A, Gryglewska B, Rewiuk K, Zarzycki B, Dzieza-Grudnik A, Kwater A, Major P, Budzynski A, Gasowski J, Grodzicki T Abstract Subclinical arterial damage connected with endothelial dysfunction is a common denominator of cardiovascular complications in a variety of metabolic diseases, including obesity. The aims of the study was to assess functional vascular changes measured by flow-mediated dilatation (FMD) and nitroglycerin-mediated dilation (NMD) of brachial artery, and to measure vascular structural alterations estimated by carotid intima-media complex thickness (IMT) in short- (10 days) and medi...
Source: Journal of Physiology and Pharmacology - Category: Drugs & Pharmacology Tags: J Physiol Pharmacol Source Type: research
ConclusionsThere are elevated levels of risk for CVD in some athletes, primarily football players. Lifestyle behaviours associated with elite athleticism, particularly football linemen potentially expose players to greater metabolic and CVD risk, which is not completely offset by sport participation.
Source: Journal of Science and Medicine in Sport - Category: Sports Medicine Source Type: research
U.S. regulators have approved a new type of cholesterol-lowering drug aimed at millions of people who don't get enough help from widely used statin pills like Lipitor and Crestor
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Publication date: Available online 21 February 2020Source: Clinica Chimica ActaAuthor(s): Wujun Chen, Yudong Wu, Qi Lu, Shuai Wang, Dongming XingAbstractApoA-I is a major protein component of high-density lipoprotein (HDL) that is widely known for regulating cholesterol trafficking and inflammatory and immune responses and for protecting against atherosclerosis. ApoA-I is generally considered to be synthesized in the liver (hepatocytes) and small intestine (enterocytes). However, computer analysis of ApoA-I has shown that the ApoA-I gene may be expressed in not only hepatocytes and enterocytes but also monocyte-macrophage ...
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
The US Food and Drug Administration on Friday approved a drug to treat high cholesterol that works differently than statins, according to Esperion Therapeutics, the company that makes the drug.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
U.S. regulators have approved a new type of cholesterol-lowering drug aimed at millions of people who don't get enough help from widely used statin pills like Lipitor and Crestor
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Esperion Therapeutics Inc said on Friday that U.S. health regulators approved its cholesterol-lowering drug, making it the first non-statin treatment to be cleared for sale in the country in nearly 20 years.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Publication date: Available online 21 February 2020Source: Life SciencesAuthor(s): Noha F. Abdelkader, Hebatollah E. Eitah, Yousreya A. Maklad, Amina A. Gamaleldin, Manal A. Badawi, Sanaa A. KenawyAbstractAimsThe use of natural agents with anti-diabetic effect in combination therapy adds further positive clinical implications in the management of diabetes mellitus. Interestingly, quercetin is one of the most potent naturally occurring antioxidant which possesses various pharmacological actions including anti-diabetic effect. Thus, this research was conducted to assess the efficiency of a new combination from gliclazide and...
Source: Life Sciences - Category: Biology Source Type: research
The non-statin drug bempedoic acid was granted approval for adults with familial hypercholesterolemia or established atherosclerotic CVD.FDA Approvals
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Alert Source Type: news
More News: Blogging | Brain | Cholesterol | Health | Insulin | Internet | Neurologists | Neurology | Neuroscience | Nutrition | Physiology | Science | Sports Medicine | Study | Sugar